BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31246565)

  • 1. The association between the OPRM1 A118G polymorphism and addiction in a Turkish population.
    Türkan H; Karahalil B; Kadıoğlu E; Eren K; Gürol DT; Karakaya AE
    Arh Hig Rada Toksikol; 2019 Jun; 70(2):97-103. PubMed ID: 31246565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.
    Schwantes-An TH; Zhang J; Chen LS; Hartz SM; Culverhouse RC; Chen X; Coon H; Frank J; Kamens HM; Konte B; Kovanen L; Latvala A; Legrand LN; Maher BS; Melroy WE; Nelson EC; Reid MW; Robinson JD; Shen PH; Yang BZ; Andrews JA; Aveyard P; Beltcheva O; Brown SA; Cannon DS; Cichon S; Corley RP; Dahmen N; Degenhardt L; Foroud T; Gaebel W; Giegling I; Glatt SJ; Grucza RA; Hardin J; Hartmann AM; Heath AC; Herms S; Hodgkinson CA; Hoffmann P; Hops H; Huizinga D; Ising M; Johnson EO; Johnstone E; Kaneva RP; Kendler KS; Kiefer F; Kranzler HR; Krauter KS; Levran O; Lucae S; Lynskey MT; Maier W; Mann K; Martin NG; Mattheisen M; Montgomery GW; Müller-Myhsok B; Murphy MF; Neale MC; Nikolov MA; Nishita D; Nöthen MM; Nurnberger J; Partonen T; Pergadia ML; Reynolds M; Ridinger M; Rose RJ; Rouvinen-Lagerström N; Scherbaum N; Schmäl C; Soyka M; Stallings MC; Steffens M; Treutlein J; Tsuang M; Wall TL; Wodarz N; Yuferov V; Zill P; Bergen AW; Chen J; Cinciripini PM; Edenberg HJ; Ehringer MA; Ferrell RE; Gelernter J; Goldman D; Hewitt JK; Hopfer CJ; Iacono WG; Kaprio J; Kreek MJ; Kremensky IM; Madden PA; McGue M; Munafò MR; Philibert RA; Rietschel M; Roy A; Rujescu D; Saarikoski ST; Swan GE; Todorov AA; Vanyukov MM; Weiss RB; Bierut LJ; Saccone NL
    Behav Genet; 2016 Mar; 46(2):151-69. PubMed ID: 26392368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].
    Gürel ŞC; Ayhan Y; Karaaslan Ç; Akel H; Karaca RÖ; Babaoğlu MÖ; Yaşar Ü; Bozkurt A; Dilbaz N; Uluğ BD; Demir B
    Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27370058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A118G mu opioid receptor polymorphism among drug addicts in Malaysia.
    Nagaya D; Ramanathan S; Ravichandran M; Navaratnam V
    J Integr Neurosci; 2012 Mar; 11(1):117-22. PubMed ID: 22744787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.
    Kapur S; Sharad S; Singh RA; Gupta AK
    J Integr Neurosci; 2007 Dec; 6(4):511-22. PubMed ID: 18181266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
    Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
    J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
    Bagher AM; Hareeri RH
    J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study.
    Al-Eitan LN; Rababa'h DM; Alghamdi MA
    BMC Psychiatry; 2021 Jan; 21(1):5. PubMed ID: 33402148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
    Daher M; Costa FM; Neves FA
    Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.
    Haerian BS; Haerian MS
    Pharmacogenomics; 2013 May; 14(7):813-24. PubMed ID: 23651028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
    Kumar D; Chakraborty J; Das S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):225-30. PubMed ID: 22138325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tetra-primer ARMS-PCR for genotyping of the OPRM1 gene rs1799971 variant associated with opioid use disorders.
    Wijekumar PJ; Ranadeva NDK; Jayamaha AR; Herath HMNDM; Noorden N; Fernando SSN
    BMC Res Notes; 2023 Nov; 16(1):333. PubMed ID: 37964305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.
    Zhang Y; Wang D; Johnson AD; Papp AC; Sadée W
    J Biol Chem; 2005 Sep; 280(38):32618-24. PubMed ID: 16046395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence.
    Franke P; Wang T; Nöthen MM; Knapp M; Neidt H; Albrecht S; Jahnes E; Propping P; Maier W
    Am J Med Genet; 2001 Jan; 105(1):114-9. PubMed ID: 11424981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.
    Clarke TK; Crist RC; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Ferraro TN; Lohoff FW; Berrettini WH
    Neurosci Lett; 2013 May; 542():71-5. PubMed ID: 23454283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among the opioid receptor gene (
    Kim KM; Choi SW; Kim D; Lee J; Kim JW
    J Behav Addict; 2019 Sep; 8(3):463-470. PubMed ID: 31553235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population.
    Ding S; Chen B; Zheng Y; Lu Q; Liu L; Zhuge QC
    BMC Psychiatry; 2013 Apr; 13():107. PubMed ID: 23560613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis.
    Arias A; Feinn R; Kranzler HR
    Drug Alcohol Depend; 2006 Jul; 83(3):262-8. PubMed ID: 16387451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response.
    Xie X; Gu J; Zhuang D; Zhou Y; Chen X; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H
    J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.